LASAGNA, ANGIOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.015
EU - Europa 704
AS - Asia 662
SA - Sud America 125
AF - Africa 30
OC - Oceania 2
Totale 2.538
Nazione #
US - Stati Uniti d'America 988
CN - Cina 201
SG - Singapore 198
IT - Italia 169
HK - Hong Kong 138
RU - Federazione Russa 133
IE - Irlanda 98
BR - Brasile 97
DE - Germania 93
FI - Finlandia 72
VN - Vietnam 46
GB - Regno Unito 38
IN - India 25
CA - Canada 14
FR - Francia 14
ZA - Sudafrica 14
PL - Polonia 13
AT - Austria 11
JP - Giappone 11
AR - Argentina 10
ES - Italia 10
BD - Bangladesh 8
SE - Svezia 8
TR - Turchia 8
NL - Olanda 7
VE - Venezuela 7
BE - Belgio 5
LT - Lituania 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
EG - Egitto 4
HR - Croazia 4
JM - Giamaica 4
MA - Marocco 4
MX - Messico 4
AZ - Azerbaigian 3
PE - Perù 3
SA - Arabia Saudita 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
DM - Dominica 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MZ - Mozambico 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 2.538
Città #
Dallas 177
Hong Kong 136
Singapore 102
Ashburn 101
Chandler 97
Dublin 94
Beijing 78
New York 71
Munich 53
Boardman 45
Helsinki 42
Los Angeles 36
Shanghai 31
Turku 30
Milan 26
Moscow 22
Redondo Beach 22
Ho Chi Minh City 20
Seattle 19
Buffalo 15
Pescara 15
Rome 15
São Paulo 15
Pavia 14
Princeton 14
Lawrence 13
Medford 12
Warsaw 11
Brooklyn 10
Denver 10
Orem 10
The Dalles 10
Tokyo 10
Chennai 9
Hanoi 9
Johannesburg 9
Düsseldorf 8
Guangzhou 8
Montreal 8
Stockholm 8
Nuremberg 7
Vienna 7
Frankfurt am Main 6
Poplar 6
San Francisco 6
Santa Clara 6
Wilmington 6
Atlanta 5
Boston 5
Columbus 5
Falkenstein 5
Houston 5
Toronto 5
Amsterdam 4
Ankara 4
Bergamo 4
Lauterbourg 4
Baku 3
Belo Horizonte 3
Biên Hòa 3
Brussels 3
Buenos Aires 3
Cairo 3
Charlotte 3
Desio 3
Dhaka 3
Lima 3
London 3
Manchester 3
Mexico City 3
Porto Alegre 3
Reggio Emilia 3
Rio de Janeiro 3
Tangier 3
Washington 3
Alghero 2
Ann Arbor 2
Bengaluru 2
Betim 2
Biassono 2
Bolu 2
Bắc Giang 2
Cagliari 2
Cajamar 2
Chicago 2
Concord 2
Darlington 2
Delhi 2
Guarulhos 2
Hangzhou 2
Hyderabad 2
Ipojuca 2
Jette 2
Jiaxing 2
Kingston 2
Livorno 2
Luanda 2
Maracaibo 2
Memphis 2
Montevideo 2
Totale 1.629
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 125
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 115
Torque teno virus and cancers: current knowledge 102
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 102
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 94
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 82
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life 76
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 75
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 73
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 72
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 72
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 71
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 71
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 70
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature 67
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? 67
How to use prophylactic G-CSF in the time of COVID-19 66
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 62
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 61
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 59
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 58
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 58
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 57
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 56
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy 52
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 52
The 'hit-and-run' strategy and viral carcinogenesis 51
Reply to Y. Ergun et al 50
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 49
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink 49
Infectious complications and immunotherapy: old pitfalls and new horizons 48
Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey 47
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 46
The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature 45
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review 44
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 42
COVID-19 and breast cancer: May the microbiome be the issue? 39
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) 36
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 36
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 32
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma 28
Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features 27
Postvaccination immune-mediated hepatitis: what do we really know? 21
Totale 2.605
Categoria #
all - tutte 13.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 1 3 1 0 0 0 1
2021/202284 6 0 1 0 4 1 10 5 2 11 7 37
2022/2023285 22 29 4 26 21 13 0 10 114 2 40 4
2023/2024350 41 51 14 22 29 85 24 31 0 11 14 28
2024/2025834 26 40 45 9 11 60 54 50 186 48 109 196
2025/20261.037 133 113 218 229 251 93 0 0 0 0 0 0
Totale 2.605